Metronidazole-induced and Wernicke encephalopathy: two different entities sharing the same metabolic pathway?
Zuccoli
G
G
Pipitone
N
N
Santa Cruz
D
D
D000890:Anti-Infective Agents / Q000493:pharmacokinetics / Q000627:therapeutic use / Q000633:toxicity*; D001921:Brain / Q000187:drug effects* / Q000473:pathology; D002529:Cerebellar Nuclei / Q000187:drug effects / Q000473:pathology; D004292:Dominance, Cerebral / Q000502:physiology; D005767:Gastrointestinal Diseases / Q000188:drug therapy; D006801:Humans; D008279:Magnetic Resonance Imaging; D008795:Metronidazole / Q000493:pharmacokinetics / Q000627:therapeutic use / Q000633:toxicity*; D013831:Thiamine / Q000037:antagonists & inhibitors; D013832:Thiamine Deficiency / Q000175:diagnosis*; D014726:Vestibular Nuclei / Q000187:drug effects / Q000473:pathology; D014899:Wernicke Encephalopathy / Q000139:chemically induced*
D000890:Anti-Infective Agents; D008795:Metronidazole; D013831:Thiamine